These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 23840738)

  • 1. Enhanced active targeting via cooperative binding of ligands on liposomes to target receptors.
    Sugiyama T; Asai T; Nedachi YM; Katanasaka Y; Shimizu K; Maeda N; Oku N
    PLoS One; 2013; 8(6):e67550. PubMed ID: 23840738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applicability of anti-neovascular therapy to drug-resistant tumor: suppression of drug-resistant P388 tumor growth with neovessel-targeted liposomal adriamycin.
    Shimizu K; Asai T; Fuse C; Sadzuka Y; Sonobe T; Ogino K; Taki T; Tanaka T; Oku N
    Int J Pharm; 2005 May; 296(1-2):133-41. PubMed ID: 15885465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a Screening System for Targeting Carriers Using Peptide-Modified Liposomes and Tissue Sections.
    Negishi Y; Hamano N; Sato H; Katagiri F; Takatori K; Endo-Takahashi Y; Kikkawa Y; Nomizu M
    Biol Pharm Bull; 2018; 41(7):1107-1111. PubMed ID: 29962407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antineovascular therapy with angiogenic vessel-targeted polyethyleneglycol-shielded liposomal DPP-CNDAC.
    Asai T; Miyazawa S; Maeda N; Hatanaka K; Katanasaka Y; Shimizu K; Shuto S; Oku N
    Cancer Sci; 2008 May; 99(5):1029-33. PubMed ID: 18294280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective delivery of an angiogenesis inhibitor by neovessel-targeted liposomes.
    Katanasaka Y; Ida T; Asai T; Maeda N; Oku N
    Int J Pharm; 2008 Aug; 360(1-2):219-24. PubMed ID: 18565703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel DDS strategy, "dual-targeting", and its application for antineovascular therapy.
    Murase Y; Asai T; Katanasaka Y; Sugiyama T; Shimizu K; Maeda N; Oku N
    Cancer Lett; 2010 Jan; 287(2):165-71. PubMed ID: 19616372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-neovascular therapy by use of tumor neovasculature-targeted long-circulating liposome.
    Maeda N; Takeuchi Y; Takada M; Sadzuka Y; Namba Y; Oku N
    J Control Release; 2004 Nov; 100(1):41-52. PubMed ID: 15491809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of the C16Y peptide on nanoparticles is an effective approach to target endothelial and cancer cells via the integrin receptor.
    Hamano N; Negishi Y; Fujisawa A; Manandhar M; Sato H; Katagiri F; Nomizu M; Aramaki Y
    Int J Pharm; 2012 May; 428(1-2):114-7. PubMed ID: 22421321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a novel cyclic RGD peptide for multiple targeting approaches of liposomes to tumor region.
    Amin M; Mansourian M; Koning GA; Badiee A; Jaafari MR; Ten Hagen TLM
    J Control Release; 2015 Dec; 220(Pt A):308-315. PubMed ID: 26526970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenic vessel-targeting DDS by liposomalized oligopeptides.
    Asai T; Oku N
    Methods Mol Biol; 2010; 605():335-47. PubMed ID: 20072892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand-targeted liposomes directed against pathological vasculature.
    Schiffelers RM; Molema G; ten Hagen TL; Janssen AP; Schraa AJ; Kok RJ; Koning GA; Storm G
    J Liposome Res; 2002; 12(1-2):129-35. PubMed ID: 12604046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of liposomal size on the targeted delivery of doxorubicin to Integrin αvβ3-expressing tumor endothelial cells.
    Kibria G; Hatakeyama H; Ohga N; Hida K; Harashima H
    Biomaterials; 2013 Jul; 34(22):5617-27. PubMed ID: 23623323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-neovascular therapy by liposomal DPP-CNDAC targeted to angiogenic vessels.
    Asai T; Shimizu K; Kondo M; Kuromi K; Watanabe K; Ogino K; Taki T; Shuto S; Matsuda A; Oku N
    FEBS Lett; 2002 Jun; 520(1-3):167-70. PubMed ID: 12044891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Size-controlled, dual-ligand modified liposomes that target the tumor vasculature show promise for use in drug-resistant cancer therapy.
    Takara K; Hatakeyama H; Kibria G; Ohga N; Hida K; Harashima H
    J Control Release; 2012 Aug; 162(1):225-32. PubMed ID: 22728515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced cancer therapy by integrative antitumor actions via systemic administration of miR-499.
    Ando H; Asai T; Koide H; Okamoto A; Maeda N; Tomita K; Dewa T; Minamino T; Oku N
    J Control Release; 2014 May; 181():32-9. PubMed ID: 24593893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of an Integrin α
    Gai Y; Jiang Y; Long Y; Sun L; Liu Q; Qin C; Zhang Y; Zeng D; Lan X
    Mol Pharm; 2020 Jan; 17(1):349-358. PubMed ID: 31829615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer antineovascular therapy with liposome drug delivery systems targeted to BiP/GRP78.
    Katanasaka Y; Ishii T; Asai T; Naitou H; Maeda N; Koizumi F; Miyagawa S; Ohashi N; Oku N
    Int J Cancer; 2010 Dec; 127(11):2685-98. PubMed ID: 20178102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposome-based glioma targeted drug delivery enabled by stable peptide ligands.
    Wei X; Gao J; Zhan C; Xie C; Chai Z; Ran D; Ying M; Zheng P; Lu W
    J Control Release; 2015 Nov; 218():13-21. PubMed ID: 26428462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer.
    Deshpande P; Jhaveri A; Pattni B; Biswas S; Torchilin V
    Drug Deliv; 2018 Nov; 25(1):517-532. PubMed ID: 29433357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RGD and interleukin-13 peptide functionalized nanoparticles for enhanced glioblastoma cells and neovasculature dual targeting delivery and elevated tumor penetration.
    Gao H; Xiong Y; Zhang S; Yang Z; Cao S; Jiang X
    Mol Pharm; 2014 Mar; 11(3):1042-52. PubMed ID: 24521297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.